Bristol-Myers Squibb Company (BMY) |
|
60.645 -0.685 (-1.12%)
|
08-07 14:55 |
|
Open: |
61.56 |
Pre. Close: |
61.33 |
|
High:
|
61.6 |
Low:
|
60.53 |
|
Volume:
|
5,176,196 |
Market Cap:
|
137,221M |
|
|
|
|
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
62.976 - 63.196 |
63.196 - 63.396 |
|
Low:
|
59.798 - 60.076 |
60.076 - 60.331 |
|
Close:
|
60.888 - 61.277 |
61.277 - 61.632 |
|
Technical analysis |
as of: 2020-08-07 2:24:33 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 73.55 One year: 85.91 |
| Support: |
Support1: 59.38 Support2: 57.16 |
| Resistance: |
Resistance1: 62.97 Resistance2: 73.55 |
| Pivot: |
59.42  |
| Moving Average: |
MA(5): 60.06 MA(20): 59.29
MA(100): 58.76 MA(250): 57.90 |
| MACD: |
MACD(12,26): 0.34 Signal(9): 0.14 |
| Stochastic oscillator: |
%K(14,3): 67.18  %D(3): 66.39 |
| RSI: |
RSI(14): 58.27 |
| 52-week: |
High: 68.34 Low: 45.32 Change(%): 30.5 |
| Average Vol(K): |
3-Month: 1390858 10-Days: 983320 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BMY has closed below upper band by 13.1%. Bollinger Bands are 50.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 07 Aug 2020
Bristol-Myers Squibb Company, (NYSE: BMY) :: Stock to track - NasdaqNewsFeed
Fri, 07 Aug 2020
Bristol-Myers Squibb (BMY) Q2 2020 Earnings Call Transcript - Motley Fool
Thu, 06 Aug 2020
Bristol Myers Squibb Earnings Top After Drug Giant Wins Eliquis Patent Fight - Investor's Business Daily
Thu, 06 Aug 2020
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Wed, 05 Aug 2020
Bristol-Myers Squibb Reports Earnings Tomorrow. Here’s What to Expect. - Barron's
Mon, 03 Aug 2020
3 Reasons Why Growth Investors Shouldn't Overlook Bristol Myers (BMY) - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug ManufacturersGeneral |
| Shares Out. (M) |
2,260 |
| Shares Float (M) |
2,260 |
|
% Held by Insiders
|
0.11 |
|
% Held by Institutions
|
79.09 |
|
Shares Short (K)
|
21,640 |
|
Shares Short P. Month (K)
|
37,320 |
Stock Financials |
|
EPS
|
0.510 |
|
EPS Est This Year
|
3.000 |
|
EPS Est Next Year
|
3.230 |
|
Book Value (p.s.)
|
22.060 |
|
Profit Margin
|
3.08 |
|
Operating Margin
|
24.63 |
|
Return on Assets (ttm)
|
5.8 |
|
Return on Equity (ttm)
|
3.0 |
|
Qtrly Rev. Growth
|
82.1 |
|
Gross Profit (p.s.)
|
8.376 |
|
Sales Per Share
|
13.721 |
|
EBITDA (p.s.)
|
5.124 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
10,570 |
|
Levered Free Cash Flow (M)
|
9,500 |
Stock Valuations |
|
PE Ratio
|
119.02 |
|
PEG Ratio
|
0.99 |
|
Price to Book value
|
2.75 |
|
Price to Sales
|
4.42 |
|
Price to Cash Flow
|
12.98 |
Stock Dividends |
|
Dividend
|
1.720 |
|
Forward Dividend
|
1.800 |
|
Dividend Yield
|
0.03 |
|
Dividend Pay Date
|
2020-08-02 |
|
Ex-Dividend Date
|
2020-07-01 |
|
7 Binary Options
|
|
Your Ad Here
|
|
